Label-free Array Systems Market (Technique: Surface Plasmon Resonance, Microcantilever, Scanning Kelvin Nanoprobe, Enthalpy Array and Others)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

According to Nova one advisor, the global Label-free Array Systems market was valued at USD 2.3 billion in 2021 and it is expected to hit around USD 4.9 billion by 2030 with a CAGR of 7.4% during the forecast period 2022 to 2030.

Label-free detection techniques are employed more often than conventional label-based detection techniques to study molecular interactions. Label-free detection has become vital in applications where label detection could compromise the target characteristic. Usage of heavy fluorescent or other labels is not necessary when using label-free array techniques to find new molecules. In comparison to the conventional labelled technique, the label-free array technique offers a number of benefits including quick delivery, dependability, reliability, and accurate real-time results. Label-free array techniques are less expensive overall, as no radioactive or fluorescent labels, tags, dye, or specialized reagents are needed for the preparation of the assay.

Advancements in material science, nanotechnology, and computational configuration have led to development of label-free microarray methods such as label-free protein microarrays and label-free biosensor arrays. These methods are quite helpful in understanding disease signaling pathway, protein profiling, biomarker screening, drug discovery, drug target identification, and drug target identification.

Report Scope of the Label-free Array Systems Market

Report Coverage

Details

Market Size

USD 4.9 Billion by 2030

Growth Rate

CAGR of 7.4% from 2022 to 2030

Largest Market

North America

Fastest Growing Market

Asia Pacific

Base Year

2021

Forecast Period

2022 to 2030

Segments Covered

Technique, Application, End-user, and Region,

Companies Mentioned

  • GE Healthcare
  • Attana AB
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories
  • GWC Technologies
  • PerkinElmer, Inc.,
  • BiOptix, Inc.

 Real-time Monitoring of Biomolecules Driving Investment in Surface Plasmon Resonance Technology

The usage of surface plasmon resonance (SPR) technology as an optical detection technique for biosensors is gaining popularity. Better understanding and acceptance of the technology is excepted to increase the usage of SPR in clinical chemistry and medicine. The global label-free array systems market size is anticipated to grow at a steady pace during the forecast period owing to the rise in awareness and acceptance of these systems. These techniques reduce cost and time, and offer high throughput results in real time. Label-free methods deliver dependable, quick, and accurate results in less time than conventional methods. Additionally, label-free methods offer real-time data on binding kinetics, affinity, and other crucial analyses, thereby cutting down on the overall processing time.

Growth in Demand for Atomic Force Microscopy to Propel Label-free Array Systems Market Share

Atomic force microscopy (AFM) is a potent method for capturing images of nearly any surface including glass, ceramics, composites, polymers, and biological material. AFM is used to quantify and locate a large spectrum of forces including magnetic force and mechanical properties. It can be used to examine cells and molecules at the nanometer scale. It can now be used to diagnose and conduct cancer research. Living cells' physicochemical characteristics change as their changes in physiological conditions. Therefore, these physicochemical characteristics could represent intricate physiological processes that take place in cells. Morphology, elasticity, and adhesion characteristics of cells can change when they are going through the carcinogenesis process and are provided external stimuli. In order to study the mechanical properties of live cells, AFM can perform atomic resolution surface imaging and ultrastructural observation of the cells under conditions that are close to physiological conditions. AFM has the potential to be used as a high-resolution research tool to study the ultrastructure and mechanical characteristics of tumor cells.

Rise in Demand for Advanced Systems that Achieve Productive Drug Discovery Processes

The cost and time required to deliver new drugs for clinical use have increased over the last three decades. Attempts to increase the number of compounds entering the drug development pipeline have largely been unsuccessful despite the rise in financial assets in research infrastructure by pharma firms and technical advances in scientific tools. Delivery of new medicines has not become effective despite the increase in cost of drug discovery projects. On the contrary, fewer medications than ever before are passing through the drug development process. The industry's overreliance on high-tech platforms, strict requirements for new drug registration & approval, and exhaustion of obvious and accessible drug targets—all these require the investigation of more complex biological systems—are the primary causes of the productivity decline. These factors are likely to drive the global label-free array systems market in the next few years.

Increase in Demand for Microcantilevers in Clinical Applications

In terms of technique, the global label-free array systems market has been classified into surface plasmon resonance, microcantilever, scanning kelvin nanoprobe, enthalpy array, atomic force microscopy, electrochemical impedance spectroscopy, interference-based technique, ellipsometry technique, and others. Microcantilevers can be used to measure a range of physical, chemical, and even biochemical variables. Microcantilever array detection increases accuracy through the usage of several sensors concurrently. This increased dependability is especially significant for practical applications. Multiple chemical or biological analysts can be detected simultaneously using group-produced microcantilever arrays. Applications could be made for clinical, industrial, military, and consumer markets. This would be particularly true once several target molecule mixtures can be examined and screened on a single, tiny chip.

Surge in Usage of Novel Targeted Drugs in Life Sciences and Pharmaceutical Industries Fueling Drug Discovery Segment

Based on application, the drug discovery segment held major share of the global market in 2021. Rise in application of label-free techniques in drug discovery, increase in R&D costs, and surge in demand for new and targeted drugs in life sciences and pharmaceutical industries are the key drivers of the drug discovery segment. Label-free methods, such as the detection and measurement of a local change in refractive index, can be used to study various interactions, including those between a drug molecule and its receptor. The drug discovery segment is anticipated to witness strong growth during the forecast period due to the increase in government funding for label-free array system market research and rise in label-free technique applications.

Rise in R&D Investments to Propel Pharmaceutical & Biotechnology Industries Segment

In terms of end-user, the global label-free array systems market has been divided into contract research organizations, academic & research institutes, pharmaceutical & biotechnology industries, and others. The pharmaceutical & biotechnology industries segment is anticipated to grow at a rapid pace in the next few years. Increase in R&D investments by pharmaceutical and biotech companies is the major factor propelling the segment. Several companies focus on the development of novel and targeted drugs in order to gain a competitive edge in the highly fragmented industry.

Regional Outlook of Global Label-free Array Systems Market

North America accounted for major share of the global label-free array systems market in 2021. The region is expected to emerge as a market leader in label-free array systems in the next few years. This can be ascribed to the increase in drug discovery programs in the U.S. owing to the rise in incidence of chronic and life-threatening diseases. In turn, this is likely to drive the demand for label-free array systems in the country. Label-free cell-based systems are also being introduced by companies for early drug discovery.

The market in Asia Pacific is expected to grow at a rapid pace during the forecast period. This can be ascribed to the growth in focus on new therapy development, availability of funds, increase in number of drug discovery projects, and rise in demand for monoclonal antibodies.

Some of the prominent players in the Label-free Array Systems Market include:

  • GE Healthcare
  • Attana AB
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories
  • GWC Technologies
  • PerkinElmer, Inc.,
  • BiOptix, Inc.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Label-free Array Systems market

  • Technique
    • Surface Plasmon Resonance
    • Microcantilever
    • Scanning Kelvin Nanoprobe
    • Enthalpy Array
    • Atomic Force Microscopy
    • Electrochemical Impedance Spectroscopy
    • Interference-based Technique
    • Ellipsometry Technique
  • Application
    • Drug Discovery
    • Biomolecular Interactions
    • Detection of Disease Biomarkers
    • Others
  • End-user
    • Contract Research Organizations
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Industries
    • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Label-free Array Systems industry analysis from 2022 to 2030 to identify the prevailing Label-free Array Systems industry opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the global Label-free Array Systems industry segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global Label-free Array Systems industry trends, key players, market segments, application areas, and market growth strategies.

Report Detail

  • Report Code:7524
  • No. of Pages:150+
  • Format:PDF/PPT/Excel

Proceed To Buy

USD 3500
USD 7000